Akiko Kume

Author PubWeight™ 6.99^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial.	Oncol Rep	2012	1.05
2	Identification of melanoma antigens using a Serological Proteome Approach (SERPA).	Cancer Genomics Proteomics	2010	0.99
3	α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.	BMC Cancer	2012	0.91
4	Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.	Int J Oncol	2013	0.90
5	Preparation of human immune effector T cells containing iron-oxide nanoparticles.	Biotechnol Bioeng	2008	0.86
6	Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.	Immunol Lett	2010	0.79
7	Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.	Cancer Immunol Immunother	2012	0.76
8	Immunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat model.	Cancer Sci	2015	0.76
9	The identification of affinity peptide ligands specific to the variable region of human antibodies.	Biomed Res	2014	0.75